Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/6/2026 | 13,399 | 0.0% | 17,360 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 9,736 | 0.0% | 17,316 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 7,725 | 0.0% | 14,715 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 10,124 | 0.0% | 15,962 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 11,908 | 0.0% | 16,717 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 19,264 | 0.0% | 18,325 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 19,099 | 0.0% | 18,172 | 6/30/2024 |
| 2024 Q1 | 5/10/2024 | 17,968 | 0.0% | 18,668 | 3/31/2024 |
| 2023 Q4 | 3/22/2024 | 15,986 | 0.0% | 18,201 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 15,060 | 0.0% | 18,300 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 13,491 | 0.0% | 18,776 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 16,055 | 0.0% | 19,539 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 14,271 | 0.0% | 19,780 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 14,343 | 0.0% | 20,822 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 12,792 | 0.0% | 21,640 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 15,767 | 0.0% | 22,577 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 14,754 | 0.0% | 23,362 | 12/31/2021 |
| 2021 Q3 | 11/5/2021 | 6,521 | 0.0% | 10,775 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 6,376 | 0.0% | 11,415 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 5,278 | 0.0% | 11,156 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 6,269 | 0.0% | 12,978 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 7,965 | 0.0% | 14,228 | 9/30/2020 |
| 2020 Q2 | 8/28/2020 | 10,172 | 0.0% | 16,310 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 7,155 | 0.0% | 14,652 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 4,191 | 0.0% | 11,158 | 12/31/2019 |
| 2014 Q2 | 8/8/2014 | 6,098 | 0.0% | 21,587 | 6/30/2014 |
| 2014 Q1 | 5/9/2014 | 5,467 | 0.0% | 18,205 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 4,925 | 0.0% | 17,890 | 12/31/2013 |